by Facundo Brotsky | Mar 11, 2024 | Left, Uncategorized
STANS, Switzerland, June 2, 2021 /PRNewswire/ — NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) (“NLS” or the “Company”), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of...
by Facundo Brotsky | Mar 11, 2024 | Left, Uncategorized
STANS, SWITZERLAND / ACCESSWIRE / August 5, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW) (“NLS” or the “Company”), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for...
by Facundo Brotsky | Mar 11, 2024 | Left, Uncategorized
STANS, SWITZERLAND / ACCESSWIRE / July 9, 2021 / Neurolynx Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) (“NRLX” or the “Company”), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients...
